Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, a person close to the matter told Fierce Pharma. More: Moderna trims digital team, lays off employees as chief information officer departs Source: fierce
read more
Significant progress for hereditary angioedema condition More: Andembry treatment approved across Europe Source: News
read more
Imaging agent to improve prostate cancer detection More: Illuccix therapy gets approval in the UK Source: News
read moreAs Alnylam approaches its highly anticipated March 23 FDA decision date for a potential expansion of Amvuttra to treat patients in an increasingly competitive indication—transthyretin amyloid cardiomyopathy (ATTR-CM)—the company is emphasizing the growth of the market. More: Alnylam touts Amvuttra's
read moreThe geographic atrophy drug can now be dosed beyond a 12-month window, a prior label restriction that led many patients to pause treatment. More: Astellas' eye med Izervay lands key FDA label update, amping up market battle with Apellis rival
read moreThe Senate on Thursday voted 52-48 to confirm President Donald Trump’s nominee for health secretary. More: It’s official: Senate votes to confirm RFK Jr. as HHS secretary Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals